BG64350B1 - Универсално приложима кръвна плазма - Google Patents

Универсално приложима кръвна плазма Download PDF

Info

Publication number: BG64350B1
Authority: BG; Bulgaria
Prior art keywords: blood; plasma; blood plasma; donors; group
Prior art date: 1997-08-05

Application number

BG104117A

Other languages

Bulgarian (bg)

English (en)

Other versions

BG104117A (en

Inventor

Wolfgang Marguerre

Tor-Einar Svae

Original Assignee

Octapharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-05

Filing date

2000-02-01

Publication date

2004-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG64350(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-02-01 Application filed by Octapharma Ag filed Critical Octapharma Ag

2000-12-29 Publication of BG104117A publication Critical patent/BG104117A/xx

2004-11-30 Publication of BG64350B1 publication Critical patent/BG64350B1/bg

Links

210000002381 plasma Anatomy 0.000 title claims abstract description 81
239000008280 blood Substances 0.000 claims abstract description 76
210000004369 blood Anatomy 0.000 claims abstract description 74
238000000034 method Methods 0.000 claims abstract description 12
230000003612 virological effect Effects 0.000 claims description 6
230000009849 deactivation Effects 0.000 claims description 4
239000000654 additive Substances 0.000 claims description 2
239000003146 anticoagulant agent Substances 0.000 claims description 2
229940127219 anticoagulant drug Drugs 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims description 2
239000003381 stabilizer Substances 0.000 claims description 2
238000004108 freeze drying Methods 0.000 claims 2
238000005507 spraying Methods 0.000 claims 2
239000007788 liquid Substances 0.000 claims 1
238000006386 neutralization reaction Methods 0.000 claims 1
238000002360 preparation method Methods 0.000 description 8
239000003599 detergent Substances 0.000 description 4
239000000047 product Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
238000001802 infusion Methods 0.000 description 2
OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
241000700605 Viruses Species 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
239000004023 fresh frozen plasma Substances 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
239000000203 mixture Substances 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
238000009928 pasteurization Methods 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
239000002994 raw material Substances 0.000 description 1
229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Developmental Biology & Embryology (AREA)
Immunology (AREA)
Virology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
External Artificial Organs (AREA)
Prostheses (AREA)

BG104117A 1997-08-05 2000-02-01 Универсално приложима кръвна плазма BG64350B1 (bg)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97113466A EP0896824A1 (en)	1997-08-05	1997-08-05	A universally applicable blood plasma

Publications (2)

Publication Number	Publication Date
BG104117A BG104117A (en)	2000-12-29
BG64350B1 true BG64350B1 (bg)	2004-11-30

Family

ID=8227172

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104117A BG64350B1 (bg)	1997-08-05	2000-02-01	Универсално приложима кръвна плазма

Country Status (24)

Country	Link
US (1)	US20110008459A1 (cs)
EP (2)	EP0896824A1 (cs)
JP (1)	JP2001513507A (cs)
CN (1)	CN1272061A (cs)
AT (1)	ATE225665T1 (cs)
AU (1)	AU742427B2 (cs)
BG (1)	BG64350B1 (cs)
BR (1)	BR9811839A (cs)
CA (1)	CA2299421C (cs)
CZ (1)	CZ293726B6 (cs)
DE (1)	DE69808620T3 (cs)
DK (1)	DK0991416T4 (cs)
EA (1)	EA003182B1 (cs)
ES (1)	ES2185218T5 (cs)
HU (1)	HU226548B1 (cs)
ID (1)	ID24308A (cs)
IL (1)	IL134308A (cs)
NO (1)	NO326216B1 (cs)
NZ (1)	NZ502661A (cs)
PL (1)	PL193983B1 (cs)
PT (1)	PT991416E (cs)
RS (1)	RS50016B (cs)
TW (1)	TW555563B (cs)
WO (1)	WO1999007390A1 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6214221B1 (en) *	1999-02-22	2001-04-10	Henry B. Kopf	Method and apparatus for purification of biological substances
CN1207004C (zh) *	2001-04-18	2005-06-22	马建川	通用型冻干血浆及其制备方法
ATE357242T1 (de) *	2003-12-19	2007-04-15	Octapharma Ag	Universell einsetzbares virus-inaktiviertes blutplasma aus teilen von plasma, das nicht von weisshäutigen stammt
EP1958618A1 (de)	2007-02-15	2008-08-20	Octapharma AG	Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
MX2011010633A (es)	2009-04-09	2012-01-20	Entegrion Inc	Productos sanguineos deshidratados por aspersion y metodos para elaborar los mismos.
US8407912B2 (en)	2010-09-16	2013-04-02	Velico Medical, Inc.	Spray dried human plasma
US20110142885A1 (en)	2009-09-16	2011-06-16	Velico Medical, Inc.	Spray-dried human plasma
FR2963737B1 (fr) *	2010-08-16	2013-04-05	Etat Francais Ministere De La Defense Service De Sante Des Armees	Procede de lyophilisation de plasma sanguin
US20140083628A1 (en)	2012-09-27	2014-03-27	Velico Medical, Inc.	Spray drier assembly for automated spray drying
EP2632580A2 (en)	2010-10-29	2013-09-04	Velico Medical, Inc.	System and method for spray drying a liquid
US9561184B2 (en)	2014-09-19	2017-02-07	Velico Medical, Inc.	Methods and systems for multi-stage drying of plasma
FR3026950A1 (fr)	2014-10-09	2016-04-15	Lab Francais Du Fractionnement	Procede de preparation de plasma universel
FR3035794B1 (fr)	2015-05-06	2017-05-05	Elicityl	Procede pour la purification du sang total ou d'un produit issu du sang
FR3035799B1 (fr)	2015-05-06	2017-05-05	Elicityl	Support pour la purification de liquides biologiques
CN111295094A (zh)	2017-10-09	2020-06-16	泰尔茂比司特生物技术有限公司	冻干容器及使用冻干容器的方法
FR3083121B1 (fr)	2018-06-27	2021-10-22	Maco Pharma Sa	Procede de greffage d un element fibreux pour l elimination d anticorps du sang ou d un composant sanguin
WO2020185916A1 (en)	2019-03-14	2020-09-17	Terumo Bct Biotechnologies, Llc	Lyophilization container fill fixture, system and method of use
DE102020212609B3 (de) *	2020-10-06	2022-04-07	Universität Greifswald	Verfahren und Vorrichtung zur Herstellung von Universalplasma
US11998861B2 (en)	2022-09-15	2024-06-04	Velico Medical, Inc.	Usability of a disposable for a spray drying plasma system
WO2024059770A1 (en)	2022-09-15	2024-03-21	Velico Medical, Inc.	Rapid spray drying system
US11975274B2 (en)	2022-09-15	2024-05-07	Velico Medical, Inc.	Blood plasma product
US12539355B2 (en)	2022-09-15	2026-02-03	Velico Medical, Inc.	Dryer for a spray drying system
US12571587B2 (en)	2022-09-15	2026-03-10	Velico Medical, Inc.	Finishing apparatus for a spray drying system
US12083447B2 (en)	2022-09-15	2024-09-10	Velico Medical, Inc.	Alignment of a disposable for a spray drying plasma system
US12246093B2 (en)	2022-09-15	2025-03-11	Velico Medical, Inc.	Methods for making spray dried plasma
US11841189B1 (en)	2022-09-15	2023-12-12	Velico Medical, Inc.	Disposable for a spray drying system
US12246266B2 (en)	2022-09-15	2025-03-11	Velico Medical, Inc.	Disposable for a spray drying system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4664913A (en) *	1982-05-24	1987-05-12	Xoma Corporation	Method for treating plasma for transfusion
US4764369A (en) *	1983-07-14	1988-08-16	New York Blood Center Inc.	Undenatured virus-free biologically active protein derivatives
US4551435A (en) *	1983-08-24	1985-11-05	Immunicon, Inc.	Selective removal of immunospecifically recognizable substances from solution
JPH0723319B2 (ja) *	1986-05-14	1995-03-15	株式会社ミドリ十字	血液製剤から血液型抗体を除去する方法
DE4008852A1 (de) †	1990-03-20	1991-09-26	Octapharma Ag	Verfahren zur herstellung von nicht-infektioesem blutplasma
US5217627A (en) *	1990-11-06	1993-06-08	Pall Corporation	System and method for processing biological fluid
JP3575770B2 (ja) *	1992-03-31	2004-10-13	学校法人藤田学園	血漿由来製剤
AU667530B2 (en) *	1992-05-28	1996-03-28	New York Blood Center, Inc., The	Removal of antibodies from blood-derived compositions while retaining coagulation factors

1997
- 1997-08-05 EP EP97113466A patent/EP0896824A1/en not_active Withdrawn
1998
- 1998-02-19 TW TW087102313A patent/TW555563B/zh not_active IP Right Cessation
- 1998-08-04 IL IL13430898A patent/IL134308A/en not_active IP Right Cessation
- 1998-08-04 CZ CZ2000370A patent/CZ293726B6/cs not_active IP Right Cessation
- 1998-08-04 HU HU0004795A patent/HU226548B1/hu not_active IP Right Cessation
- 1998-08-04 NZ NZ502661A patent/NZ502661A/xx not_active IP Right Cessation
- 1998-08-04 ID IDW20000224A patent/ID24308A/id unknown
- 1998-08-04 CA CA002299421A patent/CA2299421C/en not_active Expired - Fee Related
- 1998-08-04 ES ES98945141T patent/ES2185218T5/es not_active Expired - Lifetime
- 1998-08-04 PL PL98338794A patent/PL193983B1/pl not_active IP Right Cessation
- 1998-08-04 AU AU92569/98A patent/AU742427B2/en not_active Ceased
- 1998-08-04 PT PT98945141T patent/PT991416E/pt unknown
- 1998-08-04 DE DE69808620T patent/DE69808620T3/de not_active Expired - Lifetime
- 1998-08-04 CN CN98809602A patent/CN1272061A/zh active Pending
- 1998-08-04 DK DK98945141T patent/DK0991416T4/da active
- 1998-08-04 BR BR9811839-0A patent/BR9811839A/pt not_active Application Discontinuation
- 1998-08-04 WO PCT/EP1998/004841 patent/WO1999007390A1/en not_active Ceased
- 1998-08-04 RS YUP-58/00A patent/RS50016B/sr unknown
- 1998-08-04 AT AT98945141T patent/ATE225665T1/de active
- 1998-08-04 JP JP2000506980A patent/JP2001513507A/ja active Pending
- 1998-08-04 EP EP98945141A patent/EP0991416B2/en not_active Expired - Lifetime
- 1998-08-04 EA EA200000196A patent/EA003182B1/ru not_active IP Right Cessation
2000
- 2000-02-01 BG BG104117A patent/BG64350B1/bg unknown
- 2000-02-04 NO NO20000578A patent/NO326216B1/no not_active IP Right Cessation
2010
- 2010-09-17 US US12/923,380 patent/US20110008459A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO20000578D0 (no)	2000-02-04
RS50016B (sr)	2008-09-29
NO326216B1 (no)	2008-10-20
IL134308A (en)	2004-09-27
EP0991416A1 (en)	2000-04-12
HUP0004795A3 (en)	2003-08-28
NZ502661A (en)	2001-03-30
PL338794A1 (en)	2000-11-20
HUP0004795A2 (hu)	2001-04-28
CZ2000370A3 (cs)	2000-09-13
TW555563B (en)	2003-10-01
NO20000578L (no)	2000-03-27
CZ293726B6 (cs)	2004-07-14
DE69808620T2 (de)	2003-06-26
BR9811839A (pt)	2000-08-15
HK1026146A1 (en)	2000-12-08
ID24308A (id)	2000-07-13
ES2185218T3 (es)	2003-04-16
PT991416E (pt)	2003-02-28
ATE225665T1 (de)	2002-10-15
EA200000196A1 (ru)	2000-10-30
EA003182B1 (ru)	2003-02-27
EP0991416B1 (en)	2002-10-09
EP0896824A1 (en)	1999-02-17
CA2299421A1 (en)	1999-02-18
JP2001513507A (ja)	2001-09-04
DE69808620T3 (de)	2008-05-21
DE69808620D1 (de)	2002-11-14
US20110008459A1 (en)	2011-01-13
CN1272061A (zh)	2000-11-01
DK0991416T3 (da)	2003-02-10
CA2299421C (en)	2009-11-10
YU5800A (sh)	2003-02-28
PL193983B1 (pl)	2007-04-30
ES2185218T5 (es)	2008-04-16
AU9256998A (en)	1999-03-01
DK0991416T4 (da)	2008-02-25
AU742427B2 (en)	2002-01-03
EP0991416B2 (en)	2007-10-31
HU226548B1 (en)	2009-03-30
BG104117A (en)	2000-12-29
WO1999007390A1 (en)	1999-02-18
IL134308A0 (en)	2001-04-30

Publication	Publication Date	Title
EP0991416B1 (en)	2002-10-09	A universally applicable blood plasma
US20090092678A1 (en)	2009-04-09	Universally applicable blood plasma
DE69534187T2 (de)	2005-11-17	Sterile und pyrogenfreie säulen, gekoppelt mit einem protein, zum binden und entfernen von substanzen aus dem blut
EP2884992B1 (en)	2017-05-31	A method of preparing a growth factor concentrate derived from human platelets
AU596954B2 (en)	1990-05-24	Wound healing agents
DE69831684T2 (de)	2006-06-22	Verfahren zur Herstellung von hochvirusfreiem Thrombin zur Bereitung von Fibrinkleber aus menschlichem Plasma-Pool
DE69230381T2 (de)	2000-05-11	Rekonstituierte thrombozytenmembranvesikel
HU214884B (hu)	2000-03-28	Vérlemezke membrán mikrorészecskék, ezeket tartalmazó gyógyászati és diagnosztikai készítmények és eljárás a mikrórészecskék és a készítmények előállítására
JPH03503890A (ja)	1991-08-29	抗リンパ細胞抗体療法に使用する抗体
JPH06511013A (ja)	1994-12-08	血液、組織および生物流体のアルブミンーヨウ素保存
KR101077976B1 (ko)	2011-10-28	비-코카서스인의 혈장의 부분으로부터 생성된 범용적으로적용가능한 바이러스 불활성화 혈장
MXPA00001259A (en)	2001-11-21	A universally applicable blood plasma
RU2019190C1 (ru)	1994-09-15	Способ получения моноспецифической антисыворотки
HK1026146B (en)	2003-02-21	A universally applicable blood plasma
RU2222317C2 (ru)	2004-01-27	Средство для стимуляции эпителизации раны
RU2287345C2 (ru)	2006-11-20	Средство для стимуляции выработки фактора viii свертывания крови
DE10327066A1 (de)	2004-09-16	Bestimmung agonistischer Autoantikörper
Lavine et al.	1963	A study of the site of action of parathyroid hormone
JPS59116297A (ja)	1984-07-05	高純度のエリスロポエチンの製法
JPS63201110A (ja)	1988-08-19	プラセンタ−組織由来フイブロネクチン含有化粧料